250 related articles for article (PubMed ID: 32545922)
1. Editorial of Special Issue "Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy".
Zaza G; Gambaro G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545922
[TBL] [Abstract][Full Text] [Related]
2. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Aymé S; Bockenhauer D; Day S; Devuyst O; Guay-Woodford LM; Ingelfinger JR; Klein JB; Knoers NVAM; Perrone RD; Roberts J; Schaefer F; Torres VE; Cheung M; Wheeler DC; Winkelmayer WC;
Kidney Int; 2017 Oct; 92(4):796-808. PubMed ID: 28938953
[TBL] [Abstract][Full Text] [Related]
3. Rare inherited kidney diseases: challenges, opportunities, and perspectives.
Devuyst O; Knoers NV; Remuzzi G; Schaefer F;
Lancet; 2014 May; 383(9931):1844-59. PubMed ID: 24856029
[TBL] [Abstract][Full Text] [Related]
4. [Application of Next-Generation Sequencing in Rare Renal Diseases].
Cai ZY; Zhao JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):484-490. PubMed ID: 35791948
[TBL] [Abstract][Full Text] [Related]
5. Introduction to Genomics of Kidney Disease: Implications, Discovery, and Translation.
Sampson MG; Fox CS
Clin J Am Soc Nephrol; 2020 Feb; 15(2):267. PubMed ID: 31992576
[No Abstract] [Full Text] [Related]
6. Personalized Medicine: What's in it for Rare Diseases?
Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in rare diseases.
Ferlini A; Scotton C; Novelli G
Public Health Genomics; 2013; 16(6):313-21. PubMed ID: 24503592
[TBL] [Abstract][Full Text] [Related]
8. Rare Renal Disease in Macedonia - An Update.
Tasic V; Gucev Z; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):63-69. PubMed ID: 29668475
[TBL] [Abstract][Full Text] [Related]
9. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
[TBL] [Abstract][Full Text] [Related]
10. Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments.
Klein C; Gahl WA
EMBO Mol Med; 2018 Jan; 10(1):1-3. PubMed ID: 29180354
[TBL] [Abstract][Full Text] [Related]
11. Proteomics and personalized medicine: a focus on kidney disease.
Siwy J; Mischak H; Zürbig P
Expert Rev Proteomics; 2019 Sep; 16(9):773-782. PubMed ID: 31441341
[No Abstract] [Full Text] [Related]
12. Orphan kidney diseases.
Soliman NA
Nephron Clin Pract; 2012; 120(4):c194-9. PubMed ID: 22922418
[TBL] [Abstract][Full Text] [Related]
13. Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy.
Mariani LH; Kretzler M
Nephrol Dial Transplant; 2015 Jun; 30(6):892-8. PubMed ID: 25994659
[TBL] [Abstract][Full Text] [Related]
14. Key challenges in the treatment of rare pediatric skeletal genetic disorders: from bench to bedside.
Lorget F; Legeai-Mallet L
Drug Discov Today; 2015 Jul; 20(7):781-3. PubMed ID: 25943098
[No Abstract] [Full Text] [Related]
15. [Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases].
Fomin VV; Pulin AA; Mukhin NA
Ter Arkh; 2013; 85(6):4-9. PubMed ID: 23866592
[TBL] [Abstract][Full Text] [Related]
16. [Urinary biomarkers of kidney dysfunction].
Piéroni L; Cristol JP
Ann Biol Clin (Paris); 2015; 73(2):151-7. PubMed ID: 25847736
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine for rare neurogenetic disorders: can we make it happen?
van Eeghen AM; Bruining H; Wolf NI; Bergen AA; Houtkooper RH; van Haelst MM; van Karnebeek CD
Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35332073
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in renal disease.
Bockenhauer D; Medlar AJ; Ashton E; Kleta R; Lench N
Pediatr Nephrol; 2012 Jun; 27(6):873-83. PubMed ID: 21617915
[TBL] [Abstract][Full Text] [Related]
19. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.
Bolignano D; Nagler EV; Van Biesen W; Zoccali C
Nephrol Dial Transplant; 2014 Sep; 29(9):1628-32. PubMed ID: 24026240
[TBL] [Abstract][Full Text] [Related]
20. Editorial for Special Issue-Biomarkers of Renal Disease.
García-Estañ J; Vargas F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
